from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2118c/-

LFCtreatmentdescriptionclass of inhibitor

0.275

Amikacinug/mL Amikacintranslation

-0.460

Cap5-10ug/mL Capreomycintranslation

-1.188

Rox10-50 ug/mL Roxithromycintranslation

-0.583

SM2-5 ug/mL Streptomycintranslation

0.263

Tet5-10 ug/mL Tetracyclinetranslation

1.665

Rif0.2-5ug/mL Rifampicintranscription

1.632

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.906

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.218

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.730

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.623

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.204

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.098

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.701

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.813

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.373

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.239

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.652

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.110

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.330

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.010

KCN5-20 ug/mL Potassium cyaniderespiration

0.336

NaN30.2-2 mM Sodium aziderespiration

-0.989

Nigericin50 uM Nigericinrespiration

0.616

TRC10-150 ug/mL Triclosanrespiration

-1.475

TRZ10-25 ug/mL Thioridazinerespiration

-1.159

Valinomycin0.5-10 uM Valinomycinrespiration

-0.488

ZnSO42 mM ZnSO4respiration

0.119

menadione6-10 ug/mL Menadionerespiration

-0.319

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.176

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.923

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.146

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.339

NRP_1Non-replicating persistence stage 1dosRassociated

-0.613

Amp0.2mg/mL AmpicillincellWall

0.399

Cephalexin20-100 ug/mL CephalexincellWall

-0.018

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.210

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.000

EMB10-20 ug/mL EthambutolcellWall

-0.290

Eta12-40 ug/mL EthionamidecellWall

-0.373

INH0.2-0.4 ug/mL IsoniazidcellWall

0.351

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.219

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.093

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.429

BZA0.12 mg/mL BenzamidearomaticAmides

0.597

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.439

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.595

H2O24 mM hydrogen peroxideDNAdamaging

0.183

Levo10 ug/mL LevofloxacinDNAdamaging

0.458

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.128

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.144

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.366

UVUV-irradiationDNAdamaging

0.480

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.022

Antimycin12.5-50 ug/mL Antimycin A?

-0.328

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.469

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.116

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.746

PA8240.2-2 ug/mL PA-824?

0.757

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.637

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.220

Verapamil50 uM Verapamil?

0.564

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.457

methoxatin10-20 ug/mL Methoxatin?